241 related articles for article (PubMed ID: 26966795)
21. The muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): surveillance methodology.
Miller LA; Romitti PA; Cunniff C; Druschel C; Mathews KD; Meaney FJ; Matthews D; Kantamneni J; Feng ZF; Zemblidge N; Miller TM; Andrews J; Fox D; Ciafaloni E; Pandya S; Montgomery A; Kenneson A
Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):793-7. PubMed ID: 17036307
[TBL] [Abstract][Full Text] [Related]
22. Time to diagnosis of Duchenne muscular dystrophy remains unchanged: Findings from the Muscular Dystrophy Surveillance, Tracking, and Research Network, 2000-2015.
Thomas S; Conway KM; Fapo O; Street N; Mathews KD; Mann JR; Romitti PA; Soim A; Westfield C; Fox DJ; Ciafaloni E;
Muscle Nerve; 2022 Aug; 66(2):193-197. PubMed ID: 35312090
[TBL] [Abstract][Full Text] [Related]
23. Delayed onset of ambulation in boys with Duchenne muscular dystrophy: Potential use as an endpoint in clinical trials.
Gissy JJ; Johnson T; Fox DJ; Kumar A; Ciafaloni E; van Essen AJ; Peay HL; Martin A; Lucas A; Finkel RS;
Neuromuscul Disord; 2017 Oct; 27(10):905-910. PubMed ID: 28739181
[TBL] [Abstract][Full Text] [Related]
24. Respiratory Care Received by Individuals With Duchenne Muscular Dystrophy From 2000 to 2011.
Andrews JG; Soim A; Pandya S; Westfield CP; Ciafaloni E; Fox DJ; Birnkrant DJ; Cunniff CM; Sheehan DW;
Respir Care; 2016 Oct; 61(10):1349-59. PubMed ID: 27507176
[TBL] [Abstract][Full Text] [Related]
25. Rehabilitative technology use among individuals with Duchenne/Becker muscular dystrophy.
Pandya S; Andrews J; Campbell K; Meaney FJ
J Pediatr Rehabil Med; 2016; 9(1):45-53. PubMed ID: 26966800
[TBL] [Abstract][Full Text] [Related]
26. Disparities in the diagnostic process of Duchenne and Becker muscular dystrophy.
Holtzer C; Meaney FJ; Andrews J; Ciafaloni E; Fox DJ; James KA; Lu Z; Miller L; Pandya S; Ouyang L; Cunniff C
Genet Med; 2011 Nov; 13(11):942-7. PubMed ID: 21836521
[TBL] [Abstract][Full Text] [Related]
27. The 6-minute walk test in Duchenne/Becker muscular dystrophy: longitudinal observations.
McDonald CM; Henricson EK; Han JJ; Abresch RT; Nicorici A; Atkinson L; Elfring GL; Reha A; Miller LL
Muscle Nerve; 2010 Dec; 42(6):966-74. PubMed ID: 21038378
[TBL] [Abstract][Full Text] [Related]
28. Corticosteroid Treatments in Males With Duchenne Muscular Dystrophy: Treatment Duration and Time to Loss of Ambulation.
Kim S; Campbell KA; Fox DJ; Matthews DJ; Valdez R;
J Child Neurol; 2015 Sep; 30(10):1275-80. PubMed ID: 25414237
[TBL] [Abstract][Full Text] [Related]
29. Assessing the barriers to cardiac care in carriers of Duchenne and Becker muscular dystrophy.
Eekhoff L; Edwards J; Martin A; Prijoles EJ
J Genet Couns; 2019 Oct; 28(5):993-1002. PubMed ID: 31373078
[TBL] [Abstract][Full Text] [Related]
30. Health services received by individuals with duchenne/becker muscular dystrophy.
Pandya SK; Campbell KA; Andrews JG; Meaney FJ; Ciafaloni E
Muscle Nerve; 2016 Feb; 53(2):191-7. PubMed ID: 26044770
[TBL] [Abstract][Full Text] [Related]
31. Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy.
Barber BJ; Andrews JG; Lu Z; West NA; Meaney FJ; Price ET; Gray A; Sheehan DW; Pandya S; Yang M; Cunniff C
J Pediatr; 2013 Oct; 163(4):1080-4.e1. PubMed ID: 23866715
[TBL] [Abstract][Full Text] [Related]
32. Chart validation of an algorithm for identifying hereditary progressive muscular dystrophy in healthcare claims.
Chen X; Agiro A; Martin AS; Lucas AM; Haynes K
BMC Med Res Methodol; 2019 Aug; 19(1):174. PubMed ID: 31399066
[TBL] [Abstract][Full Text] [Related]
33. Genetics and emerging treatments for Duchenne and Becker muscular dystrophy.
Wein N; Alfano L; Flanigan KM
Pediatr Clin North Am; 2015 Jun; 62(3):723-42. PubMed ID: 26022172
[TBL] [Abstract][Full Text] [Related]
34. Use of corticosteroids in a population-based cohort of boys with duchenne and becker muscular dystrophy.
Matthews DJ; James KA; Miller LA; Pandya S; Campbell KA; Ciafaloni E; Mathews KD; Miller TM; Cunniff C; Meaney FJ; Druschel CM; Romitti PA; Fox DJ;
J Child Neurol; 2010 Nov; 25(11):1319-24. PubMed ID: 20207610
[TBL] [Abstract][Full Text] [Related]
35. Complementary and alternative medicine for Duchenne and Becker muscular dystrophies: characteristics of users and caregivers.
Zhu Y; Romitti PA; Conway KM; Andrews J; Liu K; Meaney FJ; Street N; Puzhankara S; Druschel CM; Matthews DJ
Pediatr Neurol; 2014 Jul; 51(1):71-7. PubMed ID: 24785967
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic and clinical characteristics of early-manifesting females with Duchenne or Becker muscular dystrophy.
Imbornoni L; Price ET; Andrews J; Meaney FJ; Ciafaloni E; Cunniff C
Am J Med Genet A; 2014 Nov; 164A(11):2769-74. PubMed ID: 25125379
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy.
American Academy of Pediatrics Section on Cardiology and Cardiac Surgery
Pediatrics; 2005 Dec; 116(6):1569-73. PubMed ID: 16322188
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Accuracy of Phenotype Classification in Duchenne and Becker Muscular Dystrophy Using Medical Record Data1.
Andrews JG; Lamb MM; Conway K; Street N; Westfield C; Ciafaloni E; Matthews D; Cunniff C; Pandya S; Fox DJ;
J Neuromuscul Dis; 2018; 5(4):481-495. PubMed ID: 30320597
[TBL] [Abstract][Full Text] [Related]
39. Clinical and genetic characteristics of Chinese Duchenne/Becker muscular dystrophy patients with small mutations.
Gan S; Liu S; Yang H; Wu L
Front Neurosci; 2022; 16():992546. PubMed ID: 36419457
[TBL] [Abstract][Full Text] [Related]
40. Urological manifestations of Duchenne muscular dystrophy.
Askeland EJ; Arlen AM; Erickson BA; Mathews KD; Cooper CS
J Urol; 2013 Oct; 190(4 Suppl):1523-8. PubMed ID: 23357214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
